Interpharma Public Company Limited is a Thailand-based company that develops, researches and distributes healthcare products and beauty initiatives for human beings, and healthcare products for animals. The Company provides wellness and anti-aging products, aesthetic innovation products, companion animal health products and livestock products. Its products include PREBO, YUUU toothpaste, multivitamin, Probac 7, Probac 10, Beta Glucan Plus, Pure Krill Oil, Astacurmin, YUUU cleansing mousse, Perfectha Complement, Perfectha Derm, Perfectha Deep, Perfectha Subskin and Uderma.

Employees

Sector

Pharmaceuticals

More about the company

Market Cap	2.99B 90.92M 78.19M 73.54M 67.13M 126M 8.6B 126M 872M 337M 4.4B 341M 334M 14.03B	P/E 2024	52.3x	P/E 2025	22.8x
Enterprise Value	3.11B 94.55M 81.31M 76.48M 69.81M 131M 8.94B 131M 907M 350M 4.58B 355M 347M 14.59B	EV / Sales 2024	1.13x	EV / Sales 2025	1.31x
Free-Float	-	Yield 2024 *	-	Yield 2025	1.59%

08-14	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-11	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-02	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-01	Inter Pharma Public Company Limited announces Annual dividend, payable on May 25, 2026	CI
11-11	Inter Pharma Public Company Limited (SET:IP) agreed to acquire an additional 49% stake in Interpharma- ZEAvita Company Limited from Thai Union Ingredients.	CI
11-11	Inter Pharma Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
16/04/25	Zhaoke Ophthalmology, Interpharma Strike Thailand Drug Distribution Deal	MT
16/04/25	Zhaoke Ophthalmology Limited Enters into Three Distribution and Supply Agreements with Interpharma Public Company Limited	CI
01/04/25	Inter Pharma Public Company Limited Signs Exclusive Distribution Agreement with Zhaoke Ophthalmology Company Limited for Comprehensive Eye Care Innovation	CI
25/02/25	Inter Pharma Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/02/25	Inter Pharma Public Company Limited Proposes to Omit Dividend Payment for the Year Ended December 31, 2024	CI

17/08/22	Inter Pharma : New shares of IP to be traded on August 18, 2022	PU
10/08/22	Inter Pharma Public : Notification on Change of Directors and Authorization of Directors	PU
10/08/22	Inter Pharma Public : Report on the results of sale of common shares offered to private placement (F53-5)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1 (Edited)	PU
10/08/22	Inter Pharma Public : Right Adjustment of IP-W1	PU

Manager	Title	Age	Since
Trinnawat Thanitnithiphan CEO	Chief Executive Officer	56	31/01/2014
Chatkaew Krudkosol DFI	Director of Finance/CFO	56	22/06/2023
Chompunuch Meevang CMP	Compliance Officer	54	-

Director	Title	Age	Since
Napaporn Dechakarat BRD	Director/Board Member	51	13/06/2017
Sansanee Chaiyaroj BRD	Director/Board Member	64	31/07/2020
Trinnawat Thanitnithiphan BRD	Director/Board Member	56	31/01/2014

Inter Pharma Share Price OTC Markets

Stocks

IPTB.F

TH9474010005

Pharmaceuticals

Valuation : Inter Pharma

Latest news : Inter Pharma

Press Releases : Inter Pharma

Managers and Directors : Inter Pharma

Other Pharmaceuticals

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTER PHARMA	-.--%	-.--%	-	-	92.04M
ELI LILLY AND COMPANY	-0.88%	-2.15%	+58.05%	+105.26%	1,024B
JOHNSON & JOHNSON	-1.15%	+2.68%	+54.25%	+74.19%	663B
ABBVIE INC.	-1.44%	+0.38%	+20.65%	+76.13%	453B
ROCHE HOLDING AG	-0.95%	+0.23%	+30.91%	+37.78%	352B
NOVARTIS AG	-3.18%	+1.78%	+22.62%	+41.55%	304B
ASTRAZENECA PLC	+0.30%	+0.67%	+0.60%	+11.25%	252B
AMGEN INC.	-1.55%	+1.11%	+54.15%	+75.59%	236B
NOVO NORDISK A/S	+0.02%	+2.24%	-13.83%	-55.80%	206B
GILEAD SCIENCES, INC.	-0.15%	+3.65%	+31.24%	+103.39%	187B
Average	-0.88%	+1.26%	+28.74%	+52.15%	408.71B
Weighted average by Cap.	-1.04%	+0.62%	+37.66%	+66.90%

	2024	2025
Net sales	1.91B 58.13M 49.99M 47.02M 42.92M 80.28M 5.5B 80.54M 558M 215M 2.82B 218M 214M 8.97B	2.21B 67.32M 57.89M 54.45M 49.7M 92.96M 6.37B 93.26M 646M 250M 3.26B 253M 247M 10.38B
Net income	37.28M 1.13M 975K 917K 837K 1.57M 107M 1.57M 10.87M 4.2M 54.89M 4.26M 4.16M 175M	122M 3.72M 3.2M 3.01M 2.75M 5.14M 352M 5.15M 35.69M 13.79M 180M 13.97M 13.67M 574M
Net Debt	209M 6.35M 5.46M 5.14M 4.69M 8.77M 601M 8.8M 60.92M 23.55M 308M 23.85M 23.33M 980M	119M 3.63M 3.12M 2.93M 2.68M 5.01M 343M 5.02M 34.78M 13.45M 176M 13.62M 13.32M 560M